Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Mercadolibre Inc (MELI) Price & Performance

Charles River Laboratories Intl. IncTrade
Mercadolibre IncTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Mercadolibre Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $288.87 (market cap $13.46B), while Mercadolibre Inc trades at $1,840.01 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 7.3× Charles River Laboratories Intl. Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Charles River Laboratories Intl. Inc nearer its low. Which is the better fit depends on your goals.

CRLMELI
Market Cap
$13.46B$98.35B
Sector
HealthConsumer Cyclical
52-Week High
$282.00$2.51K
52-Week Low
$145.57$1.55K
Enterprise Value
$16.30B$106.00B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $284.37, up 2.66% today and near its 52-week high, reflecting strong bullish momentum. The stock has consistently beaten earnings estimates in recent quarters, including a Q2 2026 EPS of $3.02 versus $2.77 expected, and the company raised its full-year guidance. Despite negative net income margins, operating cash flow remains robust at $738 million in 2025. Analyst sentiment is overwhelmingly positive with 26 buy ratings and a consensus price target of $277.29.

The outlook is supported by improving biotech demand and cost controls, but high valuation multiples and recent insider selling pose risks. Earnings growth and margin expansion are key catalysts, though profitability challenges and macroeconomic sensitivity could pressure the stock. Investors should weigh strong technicals and analyst support against fundamental weaknesses and execution risks.

Mercadolibre Inc

MercadoLibre (MELI) trades at $1,828.29, up 0.22% with strong technical bullish signals from moving averages. The company demonstrates exceptional revenue growth, reaching $28.89 billion in 2025, though recent earnings misses and margin pressures from strategic investments have tempered investor enthusiasm. Analyst consensus remains strongly bullish with a $2,150 price target, representing 17.6% upside potential from current levels.

MELI's growth-first strategy is driving market share gains but sacrificing near-term profitability. The stock presents a compelling opportunity for long-term investors willing to tolerate margin volatility, though execution risks and competitive pressures in Latin American e-commerce warrant careful monitoring. Current valuation at 52.77 P/E reflects premium pricing for high-growth expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Read more on MELI